We measure every patient. Here's what the data shows.
Across 3,600+ patients, JLC records validated clinical scales at intake and throughout treatment. These are the average reductions from baseline: the same numbers we report to states, providers, and families.
- 3,600+ patients treated
- Validated, gold-standard scales
- Measured before, during & after care
- EEG + digital biomarkers
eTMS brain-health outcomes
Average symptom reductions among patients in our eTMS programs for those who serve.
Average symptom and craving reductions across measured JLC eTMS patients. Source: JLC SFI Dashboard, August 25, 2026.
eTMS for Substance Use Disorder
Beginning March 2024 at Ohio addiction-treatment sites, JLC added eTMS to standard care for 177 patients, fentanyl the single largest group. Average change from baseline across all substances:
OCS · 156 patients
BSC · 153 patients
PACS · 150 patients
BDI-II · 156 patients
GAD-7 · 156 patients
ISI · 150 patients
PCL-5 · 95 patients
Fentanyl patients specifically (n = 44)
15.4 → 4.9 average score
28.3 → 11.6 average score
12.2 → 5.7 average score
16.1 → 7.6 average score
43.6 → 20.3 average score
Gold-standard scales, on every patient.
OCS (Opioid Craving) · PACS (Penn Alcohol Craving) · BSC (Brief Stimulant Craving) · PCL-5 (PTSD) · BDI-II / PHQ-9 (Depression) · GAD-7 (Anxiety) · ISI (Insomnia Severity Index)
Figures show average change from baseline across patients with that scale recorded. Lower scores mean improvement. Sample sizes (n) vary by scale. Individual results vary; these are averages, not guarantees.
Want the full outcomes brief?
We’ll send the detailed, source-cited outcomes summary and can walk your team through the live dashboard.
eTMS uses FDA-cleared transcranial magnetic stimulation technology. eTMS/MeRT is not FDA-cleared for autism spectrum disorder or substance use disorder; those uses are personalized, innovative, and not a cure. Individual results vary. Outcome figures represent average change from baseline across measured patients and are not a guarantee of results. Content is for informational purposes and is not medical advice.